Strep vaccine stirs antibody production | Science News



Support credible science journalism.

Subscribe to Science News today.


Strep vaccine stirs antibody production

10:27am, October 18, 2005

From San Francisco, at a meeting of the Infectious Diseases Society of America

An experimental vaccine against the microbe that causes strep throat can induce a potent immune response in adults, a U.S.–Canadian research team reports. The finding suggests that the vaccine is ready for large-scale testing in adults and children.

The vaccine targets group A streptococcus bacteria, which cause scarlet fever, rheumatic fever, and kidney damage as well as the throat infections that often circulate among school-age children. It also aims at the microbes—sometimes called flesh-eating bacteria—responsible for necrotizing fasciitis.

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from this issue of Science News

From the Nature Index Paid Content